期刊文献+

人类白细胞抗原单倍型相合造血干细胞移植治疗白血病 被引量:1

原文传递
导出
摘要 白血病是严重威胁人类健康的血液系统恶性肿瘤,异基因造血干细胞移植(allogeneic hematopoietic stem cell transplantation,Allo-HSCT)是治疗白血病的有效方法。目前,全世界每年进行造血干细胞移植(HSCT)的患者达10万余例。
作者 陈幸华
出处 《中华临床医师杂志(电子版)》 CAS 2012年第6期1-2,共2页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献15

  • 1吴汉新,李建勇,钱思轩,任志宏,洪鸣.非T细胞去除HLA单倍体匹配造血干细胞移植治疗白血病[J].南京医科大学学报(自然科学版),2004,24(5):491-494. 被引量:9
  • 2刘丽辉,艾辉胜.HLA半相合造血干细胞移植进展[J].国外医学(移植与血液净化分册),2004,2(4):27-30. 被引量:6
  • 3Goldman FD,Rumelhart SL,DeAlacron P,et al.Poor outcome in children with refractory or relapsed leukemia undergoing bone marrow transplantation with mismatched family menber donors.Bone Marrow Transplant,2000,25:943.
  • 4Henslee-Downey PF,Abhyankar SH,Parrish RS,et al.Use of partially mismatehed related donors extends access to allogeneic marrow transplant.Blood,1997,89:3864.
  • 5Kawano Y,Takaue Y,Watanabe A,et al.Partially mismatched pediatric transplants with allogeneic CD34(+)blood cells from a related donor.Blood,1998,92:3123-3130.
  • 6Lee KH,Lee JH,Lee JH,et al.transplantation in acute leukemia and myelodysplastic syndrome antithymocyte globulin for HLA-haploidentical hematopoietic cell Reduced-intensity conditioning therapy with busulfan,fludarabine.Blood,2011,118:2609-2617.
  • 7Aversa F,Terenzi A,Tabilio A,et al.Full haplotype-mismatched hematopoietic stem-cell transplantation:a phase II study in patients with acute leukemia at high risk of relapse.J Clin Oncol,2005,23:3447.
  • 8Chen XH,Zhang C,Zhang X,et al.Cost and outcome in stem cell collections in HLA-haplo identical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies.Transfus Apher Sci,2010,43:23-28.
  • 9Chen XH,Gao L,Zhang X,et al.HLA-haploidentical blood and marrow transplantation with antithymocyte globulin:Long-term outcome compared with HLA-identical sibling transplantation.Blood Cells Mol Dis,2009,43:98-104.
  • 10Amrolia PJ,Muccioli-Casadei G,Yvon E,et al.Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses.Blood,2003,102:2292-2299.

二级参考文献17

  • 1Aversa F, Tabilio A, Velardi A, et al. Treatment of highrisk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype [J]. N Engl J Med, 1998,339:1186-1193.
  • 2Eyrich M, Croner T, Leiler C, et al. Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells fro
  • 3Lewalle P,triffet A, Delforge A,et al. Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study [J ]. Bone Marrow Transplantation, 2003; 31:39-44.
  • 4纪树荃.一个新型单倍体造血干细胞移植方案及移植结果[C]..全国首届半匹配造血干细胞移植和非亲髓性移植学术研讨会[C].北京,2002.10-20.
  • 5Martelli MF, Reisner Y. Haploidentical ‘megadose' CD+34 cell transplants for patients with acute leukemia [J].Leukemia,2002,16:404-405.
  • 6Beatty PG,Clift RA,Mickelson EM et al. The New England Journal of Medicine . 1985
  • 7Spiter TR,McAfee SL,Dey BR,et al. Transplantation . 2003
  • 8Comoli P.Locatelli F, Moretta A et al[].Bone Marrow Transplantation.2001
  • 9Tamaki H,Ikegame K,Kawakami M et al. Leukemia . 2003
  • 10Aversa F,Velardi A,Tabilio A et al. Blood Reviews . 2001

共引文献9

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部